Investor Information
Stock Quote & Chart
Historical Price Lookup
Investment Calculator
SEC Filings
Press Releases
General
Earnings
Analyst Coverage
Corporate Governance
Board of Directors
Management
Committee Composition
Amended & Restated Audit
Committee Charter
Compensation Committee Charter
Code of Conduct and Ethics
Director Nominations Process
Stockholder Comm Policy
Whistleblower Policy
Related Party Transactions
Insider Trading Policy
Events & Presentations
Upcoming Events
Past Events
Webcasts & Presentations
Shareholder Information
Contact Information
Information Request
E-mail Alerts
Financial Information
Annual Reports
Fundamentals
Dividends & Splits
Earnings Estimates
Ownership Summary
Legal Statement
Glossary
Analyst Ratings
1-Strong Buy
4
2-Buy
5
3-Hold
0
4-Underperform
0
5-Sell
0
Mean Recommendation:
1.6
Sell
Strong Buy
Analyst Forecasts - EPS
Last Month Revisions
Fiscal Period
Mean
High
Low
Median
# of Estimates
#Up
#Down
Mean % Change
Annual
Dec 15
0.61
1.00
0.11
0.56
7
0
5
-18.10
Annual
Dec 14
0.07
0.84
-0.40
0.00
8
1
5
250.00
Annual
Dec 13
-0.32
-0.07
-0.40
-0.37
8
1
6
N/A
Quarterly
Jun 13
-0.10
-0.06
-0.12
-0.11
8
0
6
23.98
Quarterly
Sep 13
-0.08
0.15
-0.13
-0.11
8
1
5
1.67
Quarterly
Dec 13
-0.11
-0.10
-0.14
-0.11
8
0
5
33.82
Quarterly
Mar 14
-0.10
-0.03
-0.14
-0.12
4
0
2
122.22
Long Term Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Actuals - EPS
Reported EPS
Mean Estimate
Surprise % Change
Annual
Dec 12
-0.32
-0.30
-8.02
Quarterly
Jun 12
-0.02
-0.09
78.79
Quarterly
Sep 12
-0.08
-0.07
-9.80
Quarterly
Dec 12
-0.09
-0.08
-20.00
Quarterly
Mar 13
-0.03
-0.01
-350.00
Annual
Dec 11
-0.42
-0.45
6.41
Annual
Dec 10
-0.34
-0.32
-7.59
Data Provided by Thomson Reuters
Copyright © 2013 by Keryx Biopharmaceuticals, Inc.
Update Notice
|
Disclaimer
|
Contact Us